Aemetis (NASDAQ:AMTX) Stock Rating Upgraded by StockNews.com

Aemetis (NASDAQ:AMTX) was upgraded by equities researchers at StockNews.com to a “sell” rating in a research note issued on Wednesday.

Separately, HC Wainwright reissued a “buy” rating and issued a $28.00 target price on shares of Aemetis in a report on Monday, December 23rd. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have issued a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $12.95.

Aemetis Price Performance

Shares of Aemetis stock opened at $2.04 on Wednesday. The business has a 50-day moving average of $2.78 and a 200-day moving average of $2.85. The company has a market capitalization of $101.47 million, a PE ratio of -0.90 and a beta of 1.44. Aemetis has a 1-year low of $2.01 and a 1-year high of $7.03.

Aemetis (NASDAQ:AMTX) last posted its quarterly earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) EPS for the quarter, topping analysts’ consensus estimates of ($0.47) by $0.09. The firm had revenue of $81.44 million during the quarter, compared to analyst estimates of $77.79 million. During the same quarter last year, the business posted ($0.59) earnings per share. On average, equities analysts expect that Aemetis will post -2.07 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Aemetis

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Clear Harbor Asset Management LLC acquired a new stake in shares of Aemetis during the 4th quarter valued at $44,000. FMR LLC boosted its stake in shares of Aemetis by 68.2% during the 3rd quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock valued at $52,000 after buying an additional 9,137 shares during the period. SG Americas Securities LLC acquired a new stake in shares of Aemetis in the 4th quarter valued at $87,000. Barclays PLC lifted its stake in shares of Aemetis by 274.6% in the 3rd quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock valued at $109,000 after purchasing an additional 34,816 shares during the last quarter. Finally, Wellington Management Group LLP acquired a new stake in shares of Aemetis in the 3rd quarter valued at $177,000. 27.02% of the stock is currently owned by hedge funds and other institutional investors.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.